OPEG:NASDAQLeverage Shares 2X Long OPEN Daily ETF Analysis

The OPEG ETF, launched on December 10 2025, seeks 2× long exposure to the OPEN index with a daily reset, making it intrinsically short‑term in nature. At a price of $4.07 it sits well below its 20‑day ($5.97) and 50‑day ($5.86) simple moving averages, while remaining far under the 200‑day average of $7.71, signalling a bearish short‑term trend. The 14‑day RSI of 33 points reinforces the oversold condition, yet the MACD histogram is negative and the MACD line sits beneath its signal, confirming bearish momentum. Volatility is extreme, with a 30‑day realized swing of 121 % and a beta of 4.58, indicating the fund moves nearly five times the market. Since inception the ETF has posted a YTD loss of –34 % and a max drawdown of –73 %, reflecting the compounding drag of daily leverage in a choppy market. The fund’s expense ratio of 0.75 % further erodes returns, especially when compounded daily. Despite the “Extreme Greed” reading (88.9) on the fear‑and‑greed index, the underlying market pressure appears to be weakening, as evidenced by a decreasing volume trend and a support level near $3.90.
These metrics translate into a very high overall risk profile, warranting an overall risk score of 9 out of 10. The leveraged equity focus creates a high sector concentration risk, while the zero tracking error suggests the fund is accurately following its index on a day‑to‑day basis. Liquidity is a concern given modest average volumes (≈38k) and a declining volume trend, placing liquidity risk at a high level. Currency exposure is limited to USD, so currency risk remains low. For the short term we recommend a sell position with strong conviction (8/10) due to the negative YTD return, high volatility, and bearish technical signals. In the medium term a hold stance (conviction 5/10) may be justified only if investors anticipate a rapid market rally that could benefit the leveraged exposure, though the daily‑reset structure still poses decay risk. Over longer horizons the fund’s compounding effect, steep max drawdown, and elevated expense ratio make a sell recommendation (conviction 9/10) the prudent choice.